A detailed history of Rhumbline Advisers transactions in Xoma Corp stock. As of the latest transaction made, Rhumbline Advisers holds 9,695 shares of XOMA stock, worth $292,789. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,695
Previous 8,361 15.96%
Holding current value
$292,789
Previous $201,000 13.93%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

BUY
$22.31 - $26.7 $29,761 - $35,617
1,334 Added 15.96%
9,695 $229,000
Q1 2024

May 09, 2024

BUY
$19.1 - $26.32 $3,896 - $5,369
204 Added 2.5%
8,361 $201,000
Q4 2023

Feb 08, 2024

SELL
$13.82 - $19.13 $2,833 - $3,921
-205 Reduced 2.45%
8,157 $150,000
Q3 2023

Nov 09, 2023

BUY
$14.02 - $17.71 $6,701 - $8,465
478 Added 6.06%
8,362 $117,000
Q2 2023

Aug 08, 2023

BUY
$17.0 - $21.58 $134,028 - $170,136
7,884 New
7,884 $148,000
Q3 2021

Nov 12, 2021

SELL
$23.51 - $34.79 $146,396 - $216,637
-6,227 Closed
0 $0
Q2 2021

Aug 05, 2021

BUY
$29.0 - $40.64 $23,751 - $33,284
819 Added 15.14%
6,227 $212,000
Q1 2021

May 06, 2021

SELL
$33.21 - $43.99 $3,321 - $4,399
-100 Reduced 1.82%
5,408 $221,000
Q4 2020

Feb 10, 2021

BUY
$19.26 - $45.61 $106,084 - $251,219
5,508 New
5,508 $243,000

Others Institutions Holding XOMA

About XOMA Corp


  • Ticker XOMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,450,800
  • Market Cap $346M
  • Description
  • XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnolog...
More about XOMA
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.